Literature DB >> 16040626

Endothelin-mediated increases in lung VEGF content promote vascular leak in young rats exposed to viral infection and hypoxia.

Todd C Carpenter1, Stacey Schomberg, Kurt R Stenmark.   

Abstract

Viral respiratory infections increase the susceptibility of young animals to hypoxia-induced pulmonary edema formation. Previous work has shown that increased lung levels of endothelin (ET) contribute to this effect, though the mechanisms by which ET promotes vascular leak remain uncertain. Both in vitro and in vivo evidence suggests that ET can upregulate the production of VEGF, which is known to increase vascular permeability. We hypothesized that increases in lung ET promote increases in lung VEGF, which in turn increases vascular leak in the lung. Weanling rats were exposed to moderate hypoxia for 24 h while recovering from a mild viral respiratory infection, to hypoxia alone, or to viral infection alone. Lung VEGF mRNA and protein content were measured by RT-PCR and Western blotting, respectively. Animals exposed to hypoxia + virus demonstrated significant increases in lung VEGF mRNA and protein content. Immunohistochemical studies showed increased VEGF expression in alveolar septa and small pulmonary vessels in those animals. ET receptor blockade with bosentan prevented this increase in lung VEGF content, suggesting that ET promotes VEGF accumulation in the lung in this setting. Animals exposed to hypoxia + virus also demonstrated substantial increases in lung albumin extravasation, and those increases were blocked by both ET receptor blockade and VEGF antagonism. These findings suggest that ET-driven increases in lung VEGF content can contribute to the formation of pulmonary edema.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16040626     DOI: 10.1152/ajplung.00251.2005

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  15 in total

Review 1.  Endothelin B receptor, a new target in cancer immune therapy.

Authors:  Lana E Kandalaft; Andrea Facciabene; Ron J Buckanovich; George Coukos
Journal:  Clin Cancer Res       Date:  2009-06-30       Impact factor: 12.531

Review 2.  Endothelin-1 and its role in the pathogenesis of infectious diseases.

Authors:  Brandi D Freeman; Fabiana S Machado; Herbert B Tanowitz; Mahalia S Desruisseaux
Journal:  Life Sci       Date:  2014-04-26       Impact factor: 5.037

3.  HIF-1 is involved in high glucose-induced paracellular permeability of brain endothelial cells.

Authors:  Jingqi Yan; Ziyan Zhang; Honglian Shi
Journal:  Cell Mol Life Sci       Date:  2011-05-27       Impact factor: 9.261

4.  Endothelin-1, the unfolded protein response, and persistent inflammation: role of pulmonary artery smooth muscle cells.

Authors:  Michael E Yeager; Dmitry D Belchenko; Cecilia M Nguyen; Kelley L Colvin; D Dunbar Ivy; K R Stenmark
Journal:  Am J Respir Cell Mol Biol       Date:  2012-01       Impact factor: 6.914

Review 5.  Role of endothelin-1 in acute lung injury.

Authors:  Alejandro P Comellas; Arturo Briva
Journal:  Transl Res       Date:  2009-03-20       Impact factor: 7.012

6.  A potential role for reactive oxygen species and the HIF-1alpha-VEGF pathway in hypoxia-induced pulmonary vascular leak.

Authors:  David C Irwin; Joe M McCord; Eva Nozik-Grayck; Ginny Beckly; Ben Foreman; Tim Sullivan; Molly White; Joseph T Crossno; Damian Bailey; Sonia C Flores; Susan Majka; Dwight Klemm; Martha C Tissot van Patot
Journal:  Free Radic Biol Med       Date:  2009-04-07       Impact factor: 7.376

7.  Endothelial EphA receptor stimulation increases lung vascular permeability.

Authors:  Jacqueline Larson; Stacey Schomberg; William Schroeder; Todd C Carpenter
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-07-03       Impact factor: 5.464

8.  EphA2 receptor mediates increased vascular permeability in lung injury due to viral infection and hypoxia.

Authors:  Melissa A Cercone; William Schroeder; Stacey Schomberg; Todd C Carpenter
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-08-14       Impact factor: 5.464

9.  Genetic delivery of bevacizumab to suppress vascular endothelial growth factor-induced high-permeability pulmonary edema.

Authors:  Masaki Watanabe; Julie L Boyer; Ronald G Crystal
Journal:  Hum Gene Ther       Date:  2009-06       Impact factor: 5.695

10.  Pathway focused protein profiling indicates differential function for IL-1B, -18 and VEGF during initiation and resolution of lung inflammation evoked by carbon nanoparticle exposure in mice.

Authors:  Koustav Ganguly; Swapna Upadhyay; Martin Irmler; Shinji Takenaka; Katrin Pukelsheim; Johannes Beckers; Eckard Hamelmann; Holger Schulz; Tobias Stoeger
Journal:  Part Fibre Toxicol       Date:  2009-12-02       Impact factor: 9.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.